No image

VENTANA Anti-PMS2 (A16-4) Mouse Monoclonal Primary Antibody

790-5094 · Ventana Medical Systems, Inc.

For use the MMR IHC Panel

Details

Device typeHereditary nonpolyposis colon cancer (HNPCC) IVD, reagent: A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used to evaluate a clinical specimen to diagnose, monitor or predict hereditary nonpolyposis colon cancer (HNPCC) associated with mutations in one of several genes that are important in the detection and repair ofdeoxyribonucleic acid (DNA) base-pair mismatches, which may include MLH1, MSH2, MLH3, MSH6, PMS1 and PMS2.

FDA categoryImmunohistochemistry test, DNA mismatch repair (MMR) Protein assay, Lynch Syndrome Test System

Device ID07613336100592

Catalog number07862261001

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
VENTANA ANTI-MLH1 (M1) Mouse Monoclonal Primary AntibodyVentana Medical Systems, Inc.Hereditary nonpolyposis colon cancer (HNPCC) IVD, reagent	790-5091	Ventana Medical Systems, Inc.	Hereditary nonpolyposis colon cancer (HNPCC) IVD, reagent
PMS2 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.Postmeiotic segregation increased 2 (PMS2) IVD, antibody	GE087	Agilent Technologies, Inc.	Postmeiotic segregation increased 2 (PMS2) IVD, antibody
MSH2 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.MSH2 antigen IVD, antibody	GE085	Agilent Technologies, Inc.	MSH2 antigen IVD, antibody
MLH1 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.MLH1 antigen IVD, antibody	GE079	Agilent Technologies, Inc.	MLH1 antigen IVD, antibody